article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. The documents state that a partnership with a CMO would be cheaper than the state directly manufacturing insulin. This CMO will be responsible for product roll-out and distribution.

Insulin 328
article thumbnail

About the Pharma Contract Manufacturing

Creogenic Pharma

Pharma Contract Manufacturing: From the pharmaceutical sector there is a group of businesses that have tasked themselves to assist other businesses to provide better solutions to customers. When a contract manufacturing company wakes up with a customer in the business, the customer cannot control the jobs the CMO is in control of.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Antibodies Contract Manufacturing Market Size and Market Analysis

BioTech 365

The global antibodies contract manufacturing market is expected to reach from USD 13.4 Rise in demand for the production of therapeutic antibodies … Continue reading → billion in 2022 to USD 35.9 billion by 2030, registering a CAGR of 13.1% from 2022 to 2030.

article thumbnail

4th Edition Market Study into Small Molecule Drug Product Contract Manufacturer Quality – ResearchAndMarkets.com

BioTech 365

4th Edition Market Study into Small Molecule Drug Product Contract Manufacturer Quality – ResearchAndMarkets.com 4th Edition Market Study into Small Molecule Drug Product Contract Manufacturer Quality – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Small Molecule Drug Product Contract Manufacturer Quality Benchmarking (..)

article thumbnail

Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production

The Pharma Data

Under the agreement, Aurena Laboratories will establish a production unit to meet the regulatory requirements for the manufacture of Lipidor’s pharmaceutical products. This will enable Lipidor to offer potential licensees the opportunity for large-scale commercial production.

article thumbnail

Biopharmaceutical Contract Manufacturing Market, 2030 – ResearchAndMarkets.com

BioTech 365

Biopharmaceutical Contract Manufacturing Market, 2030 – ResearchAndMarkets.com Biopharmaceutical Contract Manufacturing Market, 2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Biopharmaceutical Contract Manufacturing Market by Type of Product, Scale of Operations, Expression System, Company Size, Biologics and (..)

article thumbnail

Charles River inks viral vector production pact for Navega's chronic pain gene therapy

Fierce Pharma

After charting multiple personalized medicine expansions in recent years, contract manufacturer Charles River Laboratories is back with another gene therapy pact—this time centered on an adeno-asso | After charting multiple personalized medicine expansions in recent years, contract manufacturer Charles River Laboratories is back with another gene therapy (..)